Work Package 1
CVD Burden & Inequality
WP1 is a cross-cutting work package that engages cities, citizens, community leaders, municipalities, and health and policy stakeholders. Through co-production, it defines priorities for all other WPs, focusing on how urban inequalities drive cardiovascular disease and identifying practical solutions for prevention and improved population health.
Leaders
Work Package 1 is co-led by the World Health Organization and Novartis with support from the University Medical Centre Utrecht and Menarini.
Objectives
1
Understand the burden of urban CVD in relation to health inequalities at the city level.
2
Identify targetable barriers to reducing CVD burden and health inequalities in co-creation with underserved communities.
3
Leverage existing and new composite data to better evaluate indices of obesity, hypertension, dyslipidaemia and diabetes, and their related health inequalities.
Dyslipidemia is a metabolic disorder characterized by abnormally high or low amounts of any or all lipids (fats, triglycerides, cholesterol, phospholipids) or lipoproteins in the blood.
